Chemcrux Enterprises reported a 135% year-on-year increase in standalone net profit to ₹137.43 lakh for the quarter ended June 30, 2026, driven by a 31% surge in revenue from operations. The Vadodara-based bulk drug intermediate manufacturer saw its consolidated net profit attributable to owners jump 444% to ₹50.52 lakh during the same period. The Board of Directors approved these unaudited financial results on August 4, 2026, alongside the Limited Review Report from statutory auditors Naresh & Co.

Revenue from operations stood at ₹2,193.81 lakh on a standalone basis, up from ₹1,674.74 lakh in the corresponding quarter of FY26. On a consolidated basis, which includes wholly-owned subsidiary Kalichem Private Limited, revenue was ₹2,193.82 lakh, compared to ₹1,650.35 lakh in Q1FY26. The company’s total comprehensive income for the quarter reached ₹159.22 lakh standalone and ₹72.31 lakh consolidated.

Financial Performance Highlights

The improvement in profitability was supported by controlled cost structures despite higher material consumption. Standalone cost of materials consumed rose to ₹827.51 lakh from ₹552.72 lakh in Q1FY25, while employee benefits expense increased to ₹259.05 lakh from ₹201.99 lakh. Other expenses remained stable at ₹655.12 lakh compared to ₹434.79 lakh in the previous year, reflecting operational scaling.

Basic earnings per share (EPS) improved to ₹0.93 from ₹0.39 on a standalone basis. Consolidated basic EPS rose to ₹0.34 from ₹0.06. Diluted EPS remained identical to basic EPS due to the negligible impact of employee stock options, as disclosed under Ind AS 33.

Corporate Governance and Disclosures

The Board meeting, held at the company’s registered office in Vadodara, also scheduled the 30th Annual General Meeting for September 17, 2026, via video conferencing. Dipika Rajpal, Company Secretary & Compliance Officer, signed the disclosure submitted to BSE Limited pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Naresh & Co., Chartered Accountants, issued their limited review report stating that nothing came to their attention to suggest the statements contained material misstatements. The audit covered both standalone and consolidated results, including procedures for the subsidiary Kalichem Private Limited.

What the Numbers Show

The significant divergence between standalone and consolidated profit growth warrants attention. While standalone PAT surged 135%, consolidated PAT jumped over 440%. This suggests that the subsidiary, Kalichem Private Limited, may have contributed disproportionately to the bottom-line improvement or benefited from specific one-time gains not reflected in the parent entity’s standalone figures. Additionally, the company granted 1,07,700 Employee Stock Options on May 15, 2026, under the ESOP 2025 Scheme, with associated expenses recognized in the current quarter. The implementation of the New Labour Codes effective November 21, 2025, did not materially impact the financial results, as employee benefit structures were already aligned with the new framework.

Chemcrux Enterprises Limited has incorporated a wholly owned subsidiary, Chemcrux Foundation, to fulfill its corporate social responsibility (CSR) obligations. The subsidiary was established as a Section 8 company under the Companies Act, 2013, with a certificate of incorporation issued by the Central Registration Centre on July 17, 2026. The entity is a non-profit organization with objects including the promotion of commerce, art, science, sports, education, research, social welfare, healthcare, and environmental protection.

The incorporation follows a previous intimation dated May 14, 2026, and was disclosed to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Chemcrux Foundation is classified as a related party transaction due to common directors and promoters. The subsidiary is yet to commence business operations.

The acquisition involved a cash consideration for 10,000 equity shares at a price of ₹10 per share, aggregating to ₹1,00,000. This represents 100% shareholding and control acquired by chemcrux enterprises . The entity is incorporated under the jurisdiction of the Registrar of Companies, Ahmedabad (Gujarat).

Key Details of Chemcrux Foundation

The subsidiary's primary object is to undertake CSR activities on behalf of the parent company. No specific governmental or regulatory approvals were required for this acquisition beyond the standard incorporation process.